Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
04/03/2007 | US7199113 Inhibiting tissue factor-dependent activation of blood-coagulation factors X or IX by contacting the tissue factor with a bisphosphonate blocking agent; anticoagulation |
04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
04/03/2007 | CA2183430C Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
04/03/2007 | CA2162397C Ligands for flt3 receptors |
03/29/2007 | WO2007035406A1 Antibodies to complementary peptides of thrombin or portions thereof |
03/29/2007 | US20070072869 CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS |
03/29/2007 | US20070072826 Compositions and methods for modulation of vascular structure and/or function |
03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
03/29/2007 | US20070071812 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
03/29/2007 | DE102005045518A1 New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa |
03/28/2007 | EP1767634A1 Novel galectin 8 modification protein and use thereof |
03/28/2007 | EP1767525A1 Guanidino compounds as melanocortin-4 receptor (MC4-R) agonists |
03/28/2007 | EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
03/28/2007 | EP1765411A2 Polymer-factor ix moiety conjugates |
03/28/2007 | EP1765324A2 Compositions of stable bioactive metabolites of docosahexaenoic (dha) and eicosapentaenoic (epa) acids |
03/28/2007 | EP1254944B1 Dry compositions containing hydrophobic amino acid |
03/28/2007 | CN1938294A Novel pyrrolidine-3,4-dicarboxamide derivatives |
03/28/2007 | CN1938269A Prolinyl derivatives for treating thrombosis |
03/28/2007 | CN1938058A Solid pharmaceutical preparation for dialysis |
03/28/2007 | CN1935823A Novel compound neopuerarin A and its separating method |
03/28/2007 | CN1935277A Preparation for the prophylaxis of restenosis |
03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
03/28/2007 | CN1935235A Chinese medicine injection preparation and its preparing method |
03/28/2007 | CN1935234A Chinese medicine injection preparation and its preparing method |
03/28/2007 | CN1935233A Chinese medicine injection preparation and its preparing method |
03/28/2007 | CN1935232A Chinese medicine injection preparation and its preparing method |
03/28/2007 | CN1935231A Chinese medicine injection preparation and its preparing method |
03/28/2007 | CN1935230A Chinese medicine injection preparation and its preparing method |
03/28/2007 | CN1935229A Chinese medicine injection preparation and its preparing method |
03/28/2007 | CN1935221A Medicinal liquor for treating malignant boil |
03/28/2007 | CN1935199A Quality control method for Chinese medicine compound preparation |
03/28/2007 | CN1935188A Method for preparing injection agent for promoting blood circulation |
03/28/2007 | CN1935185A Animal medicament with activating blood to promote menstruation, inducing diuresis to reduce edema, and its preparing method |
03/28/2007 | CN1935178A Ginkgo leaf extract and barrenwort extract composition |
03/28/2007 | CN1935154A Pharmaceutical use of fucoidan for treating cardio-cerebrovascular disease |
03/28/2007 | CN1935124A Tetramethylpyrazine phosphate slow-release micro-pill and its preparing method |
03/28/2007 | CN1935119A Clopidogrel sulfate solid preparation, and its preparing method |
03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
03/28/2007 | CN1307174C Imidazoquinoline derivatives |
03/28/2007 | CN1307172C 喹唑啉酮衍生物 Quinazolinone derivative |
03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
03/28/2007 | CN1306963C Remedy for diseases caused by IL-6 production |
03/28/2007 | CN1306932C Medication for lowering level of endotoxin in human blood |
03/27/2007 | US7196205 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
03/27/2007 | US7196103 Indole derivatives as factor Xa inhibitors |
03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
03/27/2007 | US7196063 Peptides and pharmaceutical compositions comprising same |
03/27/2007 | US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ |
03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
03/27/2007 | US7195640 Coated medical devices for the treatment of vulnerable plaque |
03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
03/27/2007 | CA2084552C Novel synthetic isohirudins with improved stability |
03/22/2007 | WO2007032566A1 Hematopoietic stem cell proliferator |
03/22/2007 | WO2007032557A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
03/22/2007 | WO2006091847A3 Clopidogrel base suitable for pharmaceutical formulation and preparation thereof |
03/22/2007 | WO2006016424A8 Preventive and/or therapeutic agent for calcipenia |
03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
03/22/2007 | US20070066539 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof |
03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
03/22/2007 | US20070065921 Methods and products related to producing low molecular weight heparin |
03/22/2007 | US20070065485 Therapeutic delivery of carbon monoxide |
03/22/2007 | DE102005044319A1 2-(Aminomethyl)-5-Chlor-Benzylamid-Derivate und ihre Verwendung als Hemmstoffe des Gerinnungsfaktors Xa 2- (Aminomethyl) -5-chloro-benzylamide derivatives and their use as inhibitors of coagulation factor Xa |
03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
03/22/2007 | CA2622575A1 Prok2 antagonists and methods of use |
03/22/2007 | CA2620296A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects |
03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
03/21/2007 | EP1764075A1 Tissue factor production inhibitor |
03/21/2007 | EP1763521A1 1- (indole-6-carbonyl-d-phenylglycinyl)-4- (l-methylpiperidin-4- yl) piperazine d-tartrate |
03/21/2007 | EP1696940B1 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma |
03/21/2007 | EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases |
03/21/2007 | EP1448052B1 Anti-pathogenic composition useful in blood preservation |
03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
03/21/2007 | EP1331228B1 Method of screening antiplatelet |
03/21/2007 | EP1303305B1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
03/21/2007 | EP1216259B1 Signal sequences for the production of leu-hirudine via secretion by e. coli in a culture medium |
03/21/2007 | EP0907724B1 Von willebrand factor multimerase |
03/21/2007 | CN1934252A Thrombin derivatives and medicinal composition containing the same |
03/21/2007 | CN1934122A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
03/21/2007 | CN1933729A Pesticidal composition |
03/21/2007 | CN1931878A Platelet aggregation resistant chimeric monoclonal antibody and/or its fragment |
03/21/2007 | CN1931875A High purity ulinastatin and its prepn process and medicine composition |
03/21/2007 | CN1931361A Prepn process of blood-nourishing and iron-replenishing health nutrient |
03/21/2007 | CN1931336A Chinese medicine composition and its prepn process |
03/21/2007 | CN1931293A Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process |
03/21/2007 | CN1931266A Medicine composition for treating leukopenia and its prepn process |
03/21/2007 | CN1931255A Medicine for treating thrombocytopenia and anemia and its prepn process and quality control method |
03/21/2007 | CN1931248A Medicine composition and its prepn process |
03/21/2007 | CN1931234A Medicine composition of red sage and puerarin |
03/21/2007 | CN1931233A Medicine composition of red sage and epimedium for treating cardiac and cerebral vascular diseases |
03/21/2007 | CN1931228A Lysimachia herb total flavone extract and its prepn process |
03/21/2007 | CN1931227A Prepn process of externally applied Chinese clinopodium herb prepn |
03/21/2007 | CN1931214A Medicine composition of rhodiola root and puerarin |
03/21/2007 | CN1931182A Health food for preventing and treating cardiac and cerebral vascular diseases and its production process |